前列腺癌放疗后晚期大便失禁风险的预测:来自外部独立验证的新见解
本研究在228例接受根治性放疗(IMRT,2010-2014年,处方剂量65-80 Gy)的前列腺癌患者中,外部验证Rancati等基于3DCRT人群开发的晚期大便失禁预测模型。逻辑回归确认直肠平均剂量和腹部手术史为风险因素,但结肠疾病史未获确认;校准图显示模型有区分趋势但绝对风险被低估,大分割放疗可能带来超出线性二次模型校正的额外效应。
要点
- 腹部手术史和直肠平均剂量被确认为晚期大便失禁的风险因素。
- 预测模型有区分趋势但绝对观察毒性率被低估。
- 大分割放疗可能带来超出线性二次模型校正的额外效应。
核心结论
- 研究证实既往发表的结果,即腹部手术和直肠平均剂量是晚期大便失禁的风险因素。
- 校准图提示大分割放疗可能具有超出线性二次模型校正的作用。
研究设计与样本
- 验证性研究,纳入2010-2014年接受IMRT的前列腺癌患者,处方剂量范围65-80 Gy,包括常规和大分割治疗。
- 直肠毒性采用LENT/SOMA评分,考虑至少2年随访。
- 验证Rancati等基于3DCRT人群开发的慢性大便失禁预测模型,终点为随访期间平均毒性分级,以平均FI分级>1为切点二分类。
- 模型包含直肠平均剂量(Dmean)、既往结肠疾病(COLO)和既往腹部手术(SURG)。
- 剂量采用线性二次模型校正至2 Gy/次,α/β比值=4.8 Gy。
主要发现
- 228例患者构成验证人群,25例(11%)评为平均FI分级>1。
- 逻辑回归确认文献报告的风险因素,Dmean的OR相似(1.04 ± 0.03 vs 1.06 ± 0.04),SURG的OR相似(1.9 ± 1.7 vs 1.6 ± 1.45)。
- COLO未获确认。
- 包含Dmean/Dmean+SURG的预测模型经校准图评估均显示清晰区分趋势,但绝对观察毒性率被低估,即绝对预测率始终低于相应绝对观察率。
- 该结果与大分割放疗的意外效应一致(OR = 2.20,常规组 = 8.1% vs 大分割组 = 17.4%),超出线性二次模型标准校正。
关键数值与推荐
- 验证模型以平均FI分级>1为二分类切点。
- Dmean的OR为1.04 ± 0.03(验证队列)vs 1.06 ± 0.04(原队列)。
- SURG的OR为1.9 ± 1.7(验证队列)vs 1.6 ± 1.45(原队列)。
- 大分割放疗OR = 2.20,常规组FI率8.1% vs 大分割组17.4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- COLO未获确认。
- 校准图显示绝对观察毒性率被低估,绝对预测率始终低于相应绝对观察率。
- 常规治疗组FI率(8.1%)几乎为既往研究队列(4.3%)的两倍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to validate a previously published predictive model for late fecal incontinence (FI) in a contemporary population of prostate cancer patients treated with radical radiation therapy. METHODS AND MATERIALS: The validation included patients treated with intensity-modulated radiation therapy (IMRT) (2010-2014). Prescribed dose range was 65-80 Gy, including conventional and moderate hypo-fractionated treatments. Rectal toxicity was scored using LENT/SOMA, a minimum 2-year follow up was considered. We chose to validate the model published by Rancati et al for predicting chronic FI, developed on a 3-dimensional conformal radiation therapy (3DCRT) population. It considered a longitudinal endpoint defined as the average toxicity grade during the follow up. This continuous endpoint was dichotomized using a cut-off value of mean FI grade >1. The model included mean rectal dose (Dmean), previous diseases of the colon (COLO) and previous abdominal surgery (SURG). Doses were corrected to 2 Gy/fraction using the linear-quadratic model and applying alpha/beta ratio = 4.8 Gy. RESULTS: 228 patients constituted the validation population. A mean FI grade >1 was scored in 25 patients (11%). Logistic regression confirmed risk factors reported in the literature, with similar odds ratios (ORs) for Dmean (1.04 ± 0.03 vs 1.06 ± 0.04) and SURG (1.9 ± 1.7 vs 1.6 ± 1.45); COLO was not confirmed. Consequently, the predictive models including Dmean/Dmean + SURG were evaluated using calibration plots. Both showed a clear discriminative trend, but the absolute observed toxicity rates were underestimated (ie, absolute predicted rates were always lower than corresponding absolute observed rates). This result was consistent with an unexpected effect of hypofractionation (OR = 2.20, conventional = 8.1% vs hypofractionated = 17.4%) beyond the standard correction using linear-quadratic model. Nevertheless, the FI rate in the conventionally treated group was almost double the rate observed in the previously studied cohort (4.3% vs 8.1%). CONCLUSIONS: The study confirms previously published results indicating that abdominal surgery and rectal mean dose are risk factors for late FI. Calibration plots highlight a possible role of hypofractionation beyond linear-quadratic correction.
引用
- Cicchetti A, Avuzzi B, Palorini F, et al. Predicting Late Fecal Incontinence Risk After Radiation Therapy for Prostate Cancer: New Insights From External Independent Validation. Int J Radiat Oncol Biol Phys. 2018. PMID: 29970313. doi:10.1016/j.ijrobp.2018.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。